Your browser doesn't support javascript.
loading
Immunoglobulin G levels predicts risk of recurrent adverse cardiovascular events in myocardial infarction patients.
Hally, Kathryn E; Holley, Ana S; Kristono, Gisela A; Harding, Scott A; Larsen, Peter D.
Afiliación
  • Hally KE; Wellington Cardiovascular Research Group, Wellington, New Zealand.
  • Holley AS; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
  • Kristono GA; Wellington Cardiovascular Research Group, Wellington, New Zealand.
  • Harding SA; Department of Surgery and Anaesthesia, University of Otago, Wellington, New Zealand.
  • Larsen PD; Wellington Cardiovascular Research Group, Wellington, New Zealand.
Acta Cardiol ; 75(6): 497-502, 2020 Oct.
Article en En | MEDLINE | ID: mdl-31074689
Background: Patients with myocardial infarction (MI) are at an increased risk of experiencing recurrent major adverse cardiovascular events (MACE) but predicting MACE has remained challenging. Immunoglobulins are implicated in cardiovascular disease, although the predictive value of total immunoglobulin G (IgG) has not yet been evaluated in a secondary prevention setting. This study examined whether total IgG is predictive of MACE in an MI population, and how total IgG compared to the predictive value of C-reactive protein (CRP), an acute inflammatory marker. Methods: We conducted a case-control study with 40 MI subjects (cases) who experienced MACE within 1 year of their index admission. Cases were matched for age, sex, diabetes and presentation with 77 controls who did not have MACE. Pre-discharge plasma samples were analysed for total IgG and CRP. Results: We observed higher levels of total plasma IgG in MI subjects with MACE (24.9 (16.2-43.7) mg/mL) compared to controls (18.4 (9.1-37.3) mg/mL; p < 0.05). Higher levels of IgG were associated with increased risk of MACE in our MI population. MI subjects within quartiles 3 and 4 of total IgG had 6 times and 4 times, respectively, the rate of MACE compared to subjects in quartile 1. There was no difference in CRP levels between cases and controls (1.1 (0.5-3.0) vs. 1.9 (0.6-6.1) mg/mL, p = 0.10), and no relationship was observed between CRP and MACE. Conclusion: Pre-discharge IgG level was a better marker for predicting MACE post-MI than CRP, which had no predictive value in this study.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Inmunoglobulina G / Medición de Riesgo / Infarto del Miocardio Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Acta Cardiol Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Inmunoglobulina G / Medición de Riesgo / Infarto del Miocardio Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Acta Cardiol Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Reino Unido